Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for ...

U.S. stocks are drifting near a record as Wall Street’s recent rally loses some momentum. The S&P 500 slipped 0.1% in early ...

Elevance Health Inc. (ELV), while reporting weak fourth-quarter earnings below market estimates, on Thursday issued fiscal 2025 ...

The average estimate of 17 analysts surveyed by Zacks Investment Research was for earnings of $3.80 per share. The health insurer posted revenue of $45.44 billion in the period. Its adjusted revenue ...

Health-care companies rose sharply amid strong earnings.

The headline numbers for Elevance Health (ELV) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall ...

Elevance Health posted $418 million in profit for the fourth quarter of 2024, a figure that surpassed Wall Street's ...

Wall Street was mixed in premarket trading on Thursday as major U.S. airlines stumbled and health insurance companies soared.

Premium revenue is expected to rise in the low double-digit percentage range, while product revenue rises in the low single-digit range and service fees come in flat year-over-year. Overall, operating ...

The company posted adjusted earnings per share of $3.84 for Q4 2024, falling short of the $3.98 consensus estimate. Revenue ...

Ameritas Advisory Services LLC cut its stake in Elevance Health, Inc. (NYSE:ELV – Free Report) by 4.1% in the fourth quarter, ...

Reports Q4 revenue $45B, consensus $44.72B. “As part of our commitment to elevating whole health and advancing health beyond healthcare, we ...